Table 3 Baseline features of survivor and non-survivor groups
From: Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Survivor n = 37 | Non-survivor n = 26 | P-value | |
|---|---|---|---|
Age | 61.6 (40.5–77.1) | 61.5 (42.9–73.8) | 0.769 |
Estimated GFR | 79 (46–108) | 89 (57–125) | 0.07 |
Hb, g/dl | 13.1 (7.7–16.5) | 12.8 (8–16.7) | 0.539 |
WBC × 109/mm3 | 8.4 (3.5–16.8) | 8.3 (2.5–13.9) | 0.759 |
Neutrophil × 109/mm3 | 5.3 (1.4–13.4) | 5.5 (1.5–11.6) | 0.905 |
Platelet × 109/mm3 | 285 (130–861) | 272 (127–641) | 0.916 |
LDH, U/l | 189 (127–348) | 184 (134–329) | 0.543 |
CRP, mg/dl | 21.7 (2–142) | 50 (1.2–198) | 0.180 |
Albumin, g/dl | 4.4 (3.2–5) | 4.3 (3.2–5) | 0.242 |